Singapore: Novartis oncology president, Mr Hervé Hoppenot, has stepped down from the position to pursue a career opportunity outside the organization.

Dr Alessandro Riva, Global Head, Novartis Oncology Development and Medical Affairs, will take on the role of President of Novartis Oncology ad interim, in addition to his current role, until a successor is named in due course.

Hervé has led the Oncology business since 2010.